https://www.vox.com/future-perfect/23800167/rsv-shot-infants-fda-antibodies-vaccine-flu-health
The FDA on Monday approved a new preventative treatment for respiratory syncytial virus (RSV), the leading cause of infant hospitalization in the US.
Create an account or login to join the discussion